The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
growth factor receptor genetic alterations, HER2 is genetically amplified, then like massively increasing the number of surface receptors and allowing them to actually complex together and signal in the absence of needing the growth factor itself.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so they basically turn you know through genetic mutation or alteration they turn on these — surface receptors or the immediate Downstream — signaling molecules from those surface receptors its mutations there that's the absolute like nidus if you will The Hot Spot — of where most cancers not all but where most cancers actually get their kind of you know kind of oncogenic Drive
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.